Literature DB >> 8333074

Identification of F344 rat hepatocytes transplanted within the liver of congenic analbuminemic rats by the polymerase chain reaction.

K Ogawa1, T Ohta, M Inagaki, S Nagase.   

Abstract

Hepatocytes isolated from F344 rats were transplanted into the liver of congenic albumin-deficient rats (Nagase's analbuminemic rats NAR]) by infusion into the mesenteric vein. Both albumin-positive hepatocytes in the liver and the serum albumin level increased proportionally to the number of the infused F344 hepatocytes in the recipients. However, there was no such increase in the control rats which had received transplantation of NAR hepatocytes. After the polymerase chain reaction (PCR)-mediated analysis of cDNA and genomic DNA of the recipient livers, the implantation of the F344 hepatocytes was confirmed by the increase in normal albumin mRNA and the presence of 7 bp which are missing in the NAR albumin gene. Although treatment of NAR with the 2-acetylaminofluorene diet turned albumin-negative hepatocytes to positive ones, the sequence of the normal albumin gene could not be identified in the NAR liver. This study demonstrates that the hepatocytes infused into the portal vein are readily organized into the host liver parenchyma and continue to produce albumin.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8333074     DOI: 10.1097/00007890-199307000-00002

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  2 in total

1.  Differentiation of the normal and mutant rat albumin genes on hepatic tissue sections by in situ PCR.

Authors:  Y Tokusashi; Y Nishikawa; K Ogawa
Journal:  Nucleic Acids Res       Date:  1995-09-25       Impact factor: 16.971

2.  Albumin-producing hepatocytes derived from cryopreserved F344 rat bone marrow cells transplanted in the livers of congenic Nagase's analbuminemic rats.

Authors:  Mitsuhiro Inagaki; Jun Arikura; Xiang Huiling; Xia Yan; Katsuhiko Ogawa; Shinichi Kasai
Journal:  Surg Today       Date:  2005       Impact factor: 2.549

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.